ChiCTR2500104013 版本V1.0 版本创建时间2025/06/10 09:52:34 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500104013 

最近更新日期:

Date of Last Refreshed on:

2025-06-10 09:52:28 

注册时间:

Date of Registration:

2025-06-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于家庭学校社区多维度框架儿童伤害干预模式及效果评价研究——第一阶段需求评估定量调查

Public title:

Study on the model and effect evaluation of child injury intervention based on multi-dimensional framework of home-school-community——Phase One: Quantitative Survey of Needs Assessment

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于家庭学校社区多维度框架儿童伤害干预模式及效果评价研究——第一阶段需求评估定量调查

Scientific title:

Study on the model and effect evaluation of child injury intervention based on multi-dimensional framework of home-school-community——Phase One: Quantitative Survey of Needs Assessment

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邓晓 

研究负责人:

段蕾蕾 

Applicant:

Xiao Deng 

Study leader:

Leilei Duan 

申请注册联系人电话:

Applicant telephone:

+86 186 1141 8408

研究负责人电话:

Study leader's
telephone:

+86 136 1135 5719

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

dengxiao@ncncd.chinacdc.cn

研究负责人电子邮件:

Study leader's E-mail:

duanleilei@ncncd.chinacdc.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区南纬路27号

研究负责人通讯地址:

北京市西城区南纬路27号

Applicant address:

No.27, Nanwei Street, Xicheng District, Beijing

Study leader's address:

No.27, Nanwei Street, Xicheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国疾病预防控制中心慢性非传染性疾病预防控制中心

Applicant's institution:

National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC

研究负责人所在单位:

中国疾病预防控制中心慢性非传染性疾病预防控制中心

Affiliation of the Leader:

National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

202421

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国疾控中心慢病中心伦理审查委员会

Name of the ethic committee:

Ethic Review Committee of the National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC

伦理委员会批准日期:

Date of approved by ethic committee:

2024-05-28 00:00:00

伦理委员会联系人:

王卓群

Contact Name of the ethic committee:

Zhuoqun Wang

伦理委员会联系地址:

北京市西城区南纬路27号

Contact Address of the ethic committee:

No.27, Nanwei Street, Xicheng District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 135 2165 0571

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京市卫生健康委员会

Primary sponsor:

Beijing Municipal Health Commission

研究实施负责(组长)单位地址:

北京市西城区枣林前街70号

Primary sponsor's address:

No.70, Zaolinqian Street, Xicheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

市(区县):

Country:

China

Province:

N/A

City:

单位(医院):

中国疾病预防控制中心慢性非传染性疾病预防控制中心

具体地址:

北京市西城区南纬路27号

Institution
hospital:

The National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC

Address:

No.27, Nanwei Street, Xicheng District, Beijing

经费或物资来源:

首都卫生发展科研专项

Source(s) of funding:

The capital health research and development of special

研究疾病:

伤害  

Target disease:

Injury

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

对研究地区中小学生的主要伤害问题及其影响因素进行的流行病学诊断、行为与环境诊断、教育与生态学诊断、管理与政策诊断,为构建适用于北京地区的基于家庭学校社区多维度框架中小学生伤害综合干预模式和干预措施提供依据。  

Objectives of Study:

The epidemiological diagnosis, behavioral and environmental diagnosis, educational and ecological diagnosis, and management and policy diagnosis of the main injury problems and their influencing factors among primary and secondary school students in the study area provide a basis for constructing a comprehensive intervention model and measures for student injuries based on a multidimensional framework of family, school, and community, which is applicable to the Beijing area.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 学生调查对象 纳入标准为:(1)学生:小学4-5年级学生,初中1-2年级学生,高中1-2年级学生;(2)过去12个月内在调查地区范围内居住时间累计不低于6个月。(3)能进行有效交流;(4)签署知情同意书,愿意参加本研究。 2. 项目相关单位调查对象 调查地区卫健、疾控、教育、公安、交通、消防、妇联等学生安全工作相关部门工作人员; 调查地区抽样学校所在街道办事处/乡镇政府工作人员; 调查地区抽样学校教师和工作人员。

Inclusion criteria

Inclusion Criteria for student: 1.Students in grades 4–5 of primary school, grades 1–2 of junior high school, and grades 1–2 of senior high school. 2.Have resided locally for no less than six months in last 12 months. 3.Capable of effective communication. 4.Signed informed consent form and willingness to participate in this study. Inclusion Criteria for investigation subjects related to the project 1. Staff members from relevant departments of student safety work in the investigation area, such as health and family planning, disease control, education, public security, transportation, fire control, and women's federations. 2. Staff members of the sub-district offices/township governments where the sampled schools are located in the investigation area. 3. Teachers and staff of the sampled schools in the investigation area.

排除标准:

排除标准:1)处于疾病急性期或慢性病急性发作期;2)自身存在认知或交流障碍。

Exclusion criteria:

Exclusion Criteria: 1.In the acute phase of an illness or experiencing an acute exacerbation of a chronic disease. 2.Presence of cognitive or communication impairments.

研究实施时间:

Study execute time:

From 2025-06-09 00:00:00 To 2025-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-06-09 00:00:00 To 2025-09-30 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

8508

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

通州区 

Country:

China

Province:

Beijing

City:

Tongzhou

单位(医院):

北京市通州区疾控中心 

单位级别:

无 

Institution
hospital:

Beijing Tongzhou District Center for Disease Control and Prevention

Level of the institution:

N/A

国家:

中国

省(直辖市):

北京 

市(区县):

朝阳区 

Country:

China

Province:

Beijing

City:

Chaoyang

单位(医院):

北京市朝阳区疾控中心 

单位级别:

无 

Institution
hospital:

Beijing Chaoyang District Center for Disease Control and Prevention

Level of the institution:

N/A

测量指标:

Outcomes:

指标中文名:

伤害知识正确率

指标类型:

主要指标

Outcome:

Awareness of injury related knowledge

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

伤害相关风险行为发生率

指标类型:

主要指标

Outcome:

Incidence of Injury-Related Risk Behaviors

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

伤害发生率

指标类型:

次要指标

Outcome:

Incidence of injury

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

伤害风险行为影响因素

指标类型:

次要指标

Outcome:

Injury Risk Behaviors Influencing Factors

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 7 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

在数据发表后6个月内公开原始数据,通过向研究人员申请的方式进行公开。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data will be made available to researchers upon request within six months after publication.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集 1. 学生的问卷调查由调查学校组织学生在校内集中以自填方式完成。项目工作人员将问卷统一发放至学校,并对学校负责调查老师进行调查培训,负责调查老师统一向学生发放调查问卷。现场调查实施前,需完成学生的知情同意过程。其中,高中生需本人签署知情同意书,小学生和初中生需要本人和家长均签署知情同意书。现场调查时,负责调查老师/工作人员需按照项目要求,统一向学生说明问卷填写方法并对核心概念进行解释说明,学生现场填写问卷,老师统一收集问卷。 2. 项目相关单位调查由疾控中心负责将调查表发至相关单位,并确定调查单位名单。项目相关单位相关负责人员自填完成调查表后,由疾控中心人员负责统一收集调查表。 数据管理 1. 数据将通过Epidata进行录入,设置录入逻辑校检规则,由专人、使用专门的电脑录入,电脑设有密码。双人双录入。以Excel表格形式保存。数据分析前将进行脱敏处理,去掉个人信息。 2. 将对数据的完整性、准确性、一致性等方面进行核查。 3. 数据备份将备份在一台无接触互联网的电脑上,确保数据的安全性和可恢复性。 4. 数据将进行加密,只有核心研究成员拥有数据访问权限,以保护数据的隐私和保密性。由专人负责对数据进行清洗分析,分析时注意保密原则。 5. 发布、使用信息时仅使用与健康相关信息,不涉及个人姓名、图像等隐私信息。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data Collection 1. The student questionnaire survey is organized by the schools, with students completing it through self-administration. Project staff will distribute the questionnaires uniformly to the schools and provide survey training to the teachers in charge of the survey at the schools. These teachers will then distribute the questionnaires to the students. Before the on-site survey is implemented, the informed consent process for the students must be completed. Specifically, high school students need to sign the informed consent form themselves, while primary and middle school students need both themselves and their parents to sign the informed consent form. During the survey, the teachers/staff must, in accordance with project requirements, uniformly explain to the students the method of filling out the questionnaire and provide explanations for core concepts. The students will fill out the questionnaire on-site, and the teachers will collect the questionnaires uniformly. 2. The investigation of project-related units is carried out by the Centers for Disease Control and Prevention (CDC), which is responsible for distributing the survey forms to the relevant units and determining the list of surveyed units. After the relevant personnel from the project-related units complete the survey forms through self-administration, the CDC staff will be responsible for uniformly collecting the survey forms. Data Management 1. Data will be entered through Epidata, with logical validation rules set for data entry. A dedicated person will use a specific computer to enter the data, and the computer will be password-protected. Double data entry will be conducted. The data will be saved in the form of an Excel spreadsheet. Before data analysis, data will be anonymized by removing personal information. 2. The integrity, accuracy, and consistency of the data will be verified. 3. Data backups will be stored on a computer that is not connected to the Internet, ensuring the security and recoverability of the data. 4. Data will be encrypted, and only core research members will have access to the data to protect data privacy and confidentiality. A designated person will be responsible for data cleaning and analysis, with attention to confidentiality principles during the analysis. 5. When publishing or using information, only health-related information will be used, without involving personal names, images, or other private information.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-06-10 09:52:28